FBInvestor
Stocks / Viridian Therapeutics Inc
Institutional Ownership

Viridian Therapeutics Inc

CUSIP 92790C104COMVRDNQ1 2026

Institutional Holders
218
13F filers
Shares Held
105.55M
Aggregate institutional
Institutional Value
$2.00B
Q1 2026
Net New Holders
-5
41 new · 46 closed

Institutional Ownership Trend

Aggregate 13F value by quarter

Multi-quarter trend — upgrade to see history

Upgrade

Position Activity

Q1 2026

New positions41
Increased79
Decreased67
Sold out46

Institutional Holders

218 funds hold this security · Q1 2026

#FundSharesValueΔ SharesActivity
1Fmr LLC15.38M$300.82M+994.9KAdded
2Blackrock, Inc.7.83M$153.18M+1.40MAdded
3Bellevue Group AG6.73M$131.56M+2.37MAdded
4State Street Corp4.67M$91.40M+1.21MAdded
5Fairmount Funds Management LLC3.91M$76.57M0Held
6Venrock Adviser, LLC3.88M$75.95M0Held
7Paradigm Biocapital Advisors LP3.15M$61.59M+1.71MAdded
8Wellington Management Group LLP3.08M$60.22M+1.11MAdded
9Kynam Capital Management, LP2.34M$45.80M+871.1KAdded
10Geode Capital Management, LLC2.33M$45.65M+341.0KAdded

208 more institutional holders on Premium

See every fund holding Viridian Therapeutics Inc, with full quarter-over-quarter share changes.

Unlock all holders